Jupiter Topco LLC Purchases New Stake in Cardinal Health, Inc. $CAH

Key Points

• Jupiter Topco LLC acquired 883,308 Cardinal Health shares worth approximately $209.8 million, representing about 0.38% of the company. Institutional investors collectively own 87.17% of CAH.
• Cardinal Health reported quarterly EPS of $2.91, exceeding estimates of $2.42, while revenue rose 5.8% year over year to $63.67 billion. The company maintained FY 2027 EPS guidance of $12.40–$12.60.
• Analysts remain broadly bullish, with a consensus “Moderate Buy” rating and a $266.56 price target versus the stock’s reported $238.61 price. Meanwhile, insiders sold roughly $49.6 million of shares over the past quarter.

Jupiter Topco LLC acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 883,308 shares of the company's stock, valued at approximately $209,842,000. Jupiter Topco LLC owned about 0.38% of Cardinal Health at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in CAH. BlackRock Inc. acquired a new stake in shares of Cardinal Health in the 2nd quarter worth about $6,293,115,000. State Street Corp boosted its stake in Cardinal Health by 1.8% during the 4th quarter. State Street Corp now owns 12,509,230 shares of the company's stock valued at $2,570,647,000 after purchasing an additional 221,497 shares during the last quarter. Geode Capital Management LLC boosted its stake in Cardinal Health by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company's stock valued at $1,336,750,000 after purchasing an additional 43,924 shares during the last quarter. Wellington Management Group LLP increased its holdings in Cardinal Health by 153.2% during the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company's stock worth $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Finally, Norges Bank bought a new stake in Cardinal Health during the 4th quarter worth approximately $790,344,000. 87.17% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Stephen M. Mason sold 35,000 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total value of $8,274,000.00. Following the transaction, the chief executive officer owned 18,061 shares of the company's stock, valued at $4,269,620.40. This represents a 65.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jason M. Hollar sold 80,000 shares of the company's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $235.74, for a total transaction of $18,859,200.00. Following the completion of the transaction, the chief executive officer owned 235,132 shares of the company's stock, valued at $55,430,017.68. This trade represents a 25.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 210,271 shares of company stock worth $49,626,657. 0.12% of the stock is owned by corporate insiders.

Cardinal Health Stock Up 0.3%

NYSE CAH opened at $238.61 on Thursday. The company has a market cap of $55.50 billion, a PE ratio of 33.00, a price-to-earnings-growth ratio of 1.43 and a beta of 0.49. The firm's 50-day simple moving average is $232.59 and its two-hundred day simple moving average is $218.25. Cardinal Health, Inc. has a 52 week low of $145.87 and a 52 week high of $258.30.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.42 by $0.49. The business had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The firm's revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the company earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health's payout ratio is presently 28.49%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on CAH shares. Barclays raised their target price on Cardinal Health from $258.00 to $275.00 and gave the company an "overweight" rating in a report on Thursday, August 13th. Robert W. Baird raised their price objective on Cardinal Health from $251.00 to $274.00 and gave the company an "outperform" rating in a research note on Wednesday, August 12th. Citigroup lifted their price objective on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a "buy" rating in a report on Wednesday, August 12th. TD Cowen upped their target price on shares of Cardinal Health from $275.00 to $280.00 and gave the stock a "buy" rating in a research note on Thursday, August 13th. Finally, Bank of America raised their price target on shares of Cardinal Health from $240.00 to $260.00 and gave the company a "buy" rating in a research report on Thursday, July 2nd. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $266.56.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source